SymBio Pharmaceuticals Limited (TYO:4582)
Japan · Delayed Price · Currency is JPY 56.00
0.00 (0.00%)
Oct 2, 2026, 3:30 PM JST
SymBio Pharmaceuticals Market Cap
SymBio Pharmaceuticals has a market cap or net worth of 4.49 billion as of October 2, 2026. Its market cap has decreased by -30.27% in one year.
Market Cap
4.49B
Enterprise Value
4.34B
Revenue
1.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
56.00
ChartMarket Cap Chart
Since October 20, 2011, SymBio Pharmaceuticals's market cap has decreased from 7.08B to 4.49B, a decrease of -36.59%. That is a compound annual growth rate of -3.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 4.49B | -10.65% |
| Dec 30, 2025 | 5.02B | -44.92% |
| Dec 30, 2024 | 9.12B | -12.48% |
| Dec 29, 2023 | 10.42B | -58.97% |
| Dec 30, 2022 | 25.40B | -42.20% |
| Dec 30, 2021 | 43.94B | 203.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cawachi | 84.65B |
| YAKUODO HOLDINGS | 31.39B |
| Astena Holdings | 22.16B |
| Satudora Holdings | 17.18B |
| Medical System Network | 15.23B |
| Renascience | 15.20B |
| Ohki Healthcare Holdings | 13.55B |
| Pharmarise Holdings | 5.85B |